Occult hepatitis C: How convincing are the current data?
- 24 October 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 49 (2), 665-675
- https://doi.org/10.1002/hep.22706
Abstract
No abstract availableThis publication has 104 references indexed in Scilit:
- The effects of HCV infection and management on health-related quality of lifeHepatology, 2007
- 418 Occult hepatitis C infection in patients with histological hepatitis and negative serum PCR for HCVJournal of Hepatology, 2006
- 9 Analysis of HCV persistence in patients with sustained virological responseJournal of Hepatology, 2006
- 744 Sustained virologic response (SVR) to interferon-alpha-2b +/- ribavirin therapy at 6 months reliably predicts long-term clearance of HCV at 5-year follow-upJournal of Hepatology, 2006
- Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis CJournal of Hepatology, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantationTransplant Immunology, 2004
- Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis CEuropean Journal of Pediatrics, 2003
- Extrahepatic manifestations of hepatitis C among United States male veteransHepatology, 2002
- Replication of hepatitis C virus in peripheral blood mononuclear cells: Effect of alpha-interferon therapyJournal of Hepatology, 1992